ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Nacher M, Huber F, El Guedj M, Vaz T, Magnien C, Djossou F, Randrianjohany A, Alvarez F, Couppié P, 2007. Risk factors for death among patients in French Guiana: 1996–2005. HIV Med 8: 472–474.
-
2.
Nacher M, Vantilcke V, Parriault MC, Van Melle A, Hanf M, Labadie G, Romeo M, Adriouch L, Carles G, Couppié P, 2010. What is driving the HIV epidemic in French Guiana? Int J STD AIDS 21: 359–361.
-
3.
Nacher M, 2007. Activity Report of HIV Patient Care in French Guiana in 2007. Available at: www.corevih.org. Accessed June 27, 2013.
-
4.
Kazanji M, Gessain A, 2003. Human T-cell lymphotropic virus types I and II (HTLV-I/II) in French Guiana: clinical and molecular epidemiology. Cad Saude Publica 19: 1227–1240.
-
5.
Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E, 2007. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 7: 266–281.
-
6.
Plancoulaine S, Gessain A, Joubert M, Tortevoye P, Jeanne I, Talarmin A, de Thé G, Abel L, 2000. Detection of a major gene predisposing to human T lymphotropic virus type I infection in children among an endemic population of African origin. J Infect Dis 182: 405–412.
-
7.
Casoli C, Pilotti E, Bertazzoni U, 2007. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression. AIDS Rev 9: 140–149.
-
8.
Beilke MA, Traina-Dorge VL, Sirois M, Bhuiyan A, Murphy EL, Walls JM, Fagan R, Winsor EL, Kissinger PJ, 2007. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection. Clin Infect Dis 44: 1229–1234.
-
9.
Brites C, Sampalo J, Oliveira A, 2009. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression. AIDS Rev 11: 8–16.
-
10.
Sobesky M, Couppie P, Pradinaud R, Godard MC, Alvarez F, Benoit B, Carme B, Lebeux P, 2000. Coinfection with HIV and HTLV-I infection and survival in AIDS stage. French Guiana Study. GECVIG (Clinical HIV Study Group in Guiana). Presse Med 29: 413–416.
-
11.
Cabié A, 2012. Activity Report of the COREVIH Martinique. Available at: http://www.sfls.aei.fr/ckfinder/userfiles/files/BAO-CoreVIH/bao8/RA_2011_COREVIH_Martinique.pdf. Accessed June 27, 2013.
-
12.
Césaire R, Lagathu G, Lézin A. 2005. HTLV1 and associated diseases in the French Antilles and French Guiana. Revue Francophone des Laboratoires 2005: 35–44.
-
13.
Plancoulaine S, Buigues RP, Murphy EL, van Beveren M, Pouliquen JF, Joubert M, Rémy F, Tuppin P, Tortevoye P, de Thé G, Moreau JP, Gessain A, 1998. Demographic and familial characteristics of HTLV-1 infection among an isolated, highly endemic population of African origin in French Guiana. Int J Cancer 76: 331–336.
-
14.
Beilke MA, Theall KP, Megan O, Clayton JL, Benjamin SM, Winsor EL, Kissinger PJ, 2004. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2. Clin Infect Dis 39: 256–263.
-
15.
Schechter M, Harrison LH, Halsey NA, Trade G, Santino M, Moulton LH, Quinn TC, 1994. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression. JAMA 271: 353–357.
-
16.
Oni T, Djossou F, Joubert M, Heraud JM, 2006. Awareness of mother-to-child transmission of human T-cell lymphotropic virus (HTLV) type I through breastfeeding in a small group of HTLV-positive women in Maripasoula and Papaichton, French Guiana. Trans R Soc Trop Med Hyg 100: 715–718.
-
17.
Schechter M, Moulton LH, Harrison LH, 1997. HIV viral load and CD4+ lymphocyte counts in subjects coinfected with HTLV-I and HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol 15: 308–311.
-
18.
Brites C, Alencar R, Gusmao R, Pedroso C, Netto EM, Pedral-Sampaio D, Badaró R, 2001. Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, Brazil. AIDS 15: 2053–2055.
-
19.
Gudo ES, Bhatt NB, Bila DR, Abreu CM, Tanuri A, Savino W, Silva-Barbosa SD, Jani IV, 2009. Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS? BMC Infect Dis 9: 211.
-
20.
Scapellato PG, Bottaro E, Brieschke MT, Scapellato JL, Dato A, Intile AD, Davaro R, Vidal GI, 2003. CD4 cell count among HIV-infected patients with an AIDS-defining disease: higher count in patients coinfected than in those not coinfected with human T-cell lymphotropic virus type I. J Acquir Immune Defic Syndr 33: 279–280.
-
21.
Bessinger R, Beilke M, Kissinger P, Jarrott C, Tabak OF, 1997. Retroviral coinfections at a New Orleans HIV outpatient clinic. J Acquir Immune Defic Syndr Hum Retrovirol 14: 67–71.
-
22.
Harrison LH, Quinn TC, Schechter M, 1997. Human T cell lymphotropic virus type I does not increase human immunodeficiency virus viral load in vivo. J Infect Dis 175: 438–440.
-
23.
Cardoso DF, Souza FV, Fonseca LA, Duarte AJ, Casseb J, 2009. Influence of human T-cell lymphotropic virus type 1 (HTLV-1) infection on laboratory parameters of patients with chronic hepatitis C virus. Rev Inst Med Trop Sao Paulo 51: 325–329.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 317 | 263 | 5 |
| Full Text Views | 283 | 10 | 1 |
| PDF Downloads | 65 | 9 | 1 |
Predictive Factors of HTLV1-HIV Coinfections in French Guiana
Elise Gouhier
Elise Gouhier
Departement des Maladies Infectieuses, Cayenne General Hospital, French Guiana; COREVIH Guyane, Cayenne General Hospital, French Guiana; Department of Dermatology, Cayenne General Hospital, Cayenne, French Guiana; Centre d'Investigation Clinique Epidémiologie Clinique Antilles Guyane CIC-EC CIE INSERM 802, Cayenne General Hospital, Cayenne, French Guiana; Equipe EPaT EA3593 Epidemiologie des Parasitoses et Mycoses Tropicales, Universite Antilles Guyane; Equipe EA 3593, Université des Antilles et de la Guyane
Search for other papers by Elise Gouhier in
Current site
Google Scholar
PubMed
Search for other papers by Elise Gouhier in
Current site
Google Scholar
PubMed
Emilie Gaubert-Maréchal
Emilie Gaubert-Maréchal
Departement des Maladies Infectieuses, Cayenne General Hospital, French Guiana; COREVIH Guyane, Cayenne General Hospital, French Guiana; Department of Dermatology, Cayenne General Hospital, Cayenne, French Guiana; Centre d'Investigation Clinique Epidémiologie Clinique Antilles Guyane CIC-EC CIE INSERM 802, Cayenne General Hospital, Cayenne, French Guiana; Equipe EPaT EA3593 Epidemiologie des Parasitoses et Mycoses Tropicales, Universite Antilles Guyane; Equipe EA 3593, Université des Antilles et de la Guyane
Search for other papers by Emilie Gaubert-Maréchal in
Current site
Google Scholar
PubMed
Search for other papers by Emilie Gaubert-Maréchal in
Current site
Google Scholar
PubMed
Philippe Abboud
Philippe Abboud
Departement des Maladies Infectieuses, Cayenne General Hospital, French Guiana; COREVIH Guyane, Cayenne General Hospital, French Guiana; Department of Dermatology, Cayenne General Hospital, Cayenne, French Guiana; Centre d'Investigation Clinique Epidémiologie Clinique Antilles Guyane CIC-EC CIE INSERM 802, Cayenne General Hospital, Cayenne, French Guiana; Equipe EPaT EA3593 Epidemiologie des Parasitoses et Mycoses Tropicales, Universite Antilles Guyane; Equipe EA 3593, Université des Antilles et de la Guyane
Search for other papers by Philippe Abboud in
Current site
Google Scholar
PubMed
Search for other papers by Philippe Abboud in
Current site
Google Scholar
PubMed
Pierre Couppié
Pierre Couppié
Departement des Maladies Infectieuses, Cayenne General Hospital, French Guiana; COREVIH Guyane, Cayenne General Hospital, French Guiana; Department of Dermatology, Cayenne General Hospital, Cayenne, French Guiana; Centre d'Investigation Clinique Epidémiologie Clinique Antilles Guyane CIC-EC CIE INSERM 802, Cayenne General Hospital, Cayenne, French Guiana; Equipe EPaT EA3593 Epidemiologie des Parasitoses et Mycoses Tropicales, Universite Antilles Guyane; Equipe EA 3593, Université des Antilles et de la Guyane
Search for other papers by Pierre Couppié in
Current site
Google Scholar
PubMed
Search for other papers by Pierre Couppié in
Current site
Google Scholar
PubMed
Mathieu Nacher
Mathieu Nacher
Departement des Maladies Infectieuses, Cayenne General Hospital, French Guiana; COREVIH Guyane, Cayenne General Hospital, French Guiana; Department of Dermatology, Cayenne General Hospital, Cayenne, French Guiana; Centre d'Investigation Clinique Epidémiologie Clinique Antilles Guyane CIC-EC CIE INSERM 802, Cayenne General Hospital, Cayenne, French Guiana; Equipe EPaT EA3593 Epidemiologie des Parasitoses et Mycoses Tropicales, Universite Antilles Guyane; Equipe EA 3593, Université des Antilles et de la Guyane
Search for other papers by Mathieu Nacher in
Current site
Google Scholar
PubMed
Search for other papers by Mathieu Nacher in
Current site
Google Scholar
PubMed
French Guiana, the French territory most affected by human immunodeficiency virus (HIV) (1.3% of pregnant women), is also endemic for human T lymphotropic virus 1 (HTLV1). The objective of this study was to determine if the HTLV1/HIV coinfected patients had particular characteristics. All HIV-infected patients having a computerized medical file containing an HTLV1 serology were included: there were 1,333 HIV monoinfections and 76 HTLV1/VIH coinfections. The prevalence of HTLV1/HIV coinfections was 5.39%. Women (odds ratio [OR] = 1.91[1.13–3.24]), subjects > 40 years of age, and patients of Surinamese origin (OR = 2.65 [1.25–5.61]) were overrepresented among the coinfected. CD4 count at the time of diagnosis and viral loads were higher among coinfected patients. The clinical stage was not significantly different between the two groups. The number of CD4 cells was not higher among the coinfected, unlike most reports from the literature. Prevalence of HTLV1 among HIV-infected patients is high in French Guiana, and physicians seem to omit the prescription of serology for this potentially serious coinfection.
Author Notes
Authors' addresses: Elise Gouhier and Philippe Abboud, Centre Hospitalier de Cayenne, Departement des Maladies Infectieuses, Cayenne, French Guiana, E-mails: elisegouhier@hotmail.com and philippe.abboud@ch-cayenne.fr. Emilie Gaubert-Maréchal, Centre Hospitalier de Cayenne – COREVIH, Cayenne, French Guiana, E-mail: emilie.gaubert-maréchal@ch-cayenne.fr. Pierre Couppié, Centre Hospitalier de Cayenne, Cayenne, French Guiana, Service de Dermatologie, Cayenne, French Guiana, E-mail: couppie.pierre@voila.fr. Mathieu Nacher, CH Cayenne, Rue des Flamboyants, Cayenne, E-mail: mathieu.nacher@ch-cayenne.fr.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Nacher M, Huber F, El Guedj M, Vaz T, Magnien C, Djossou F, Randrianjohany A, Alvarez F, Couppié P, 2007. Risk factors for death among patients in French Guiana: 1996–2005. HIV Med 8: 472–474.
-
2.
Nacher M, Vantilcke V, Parriault MC, Van Melle A, Hanf M, Labadie G, Romeo M, Adriouch L, Carles G, Couppié P, 2010. What is driving the HIV epidemic in French Guiana? Int J STD AIDS 21: 359–361.
-
3.
Nacher M, 2007. Activity Report of HIV Patient Care in French Guiana in 2007. Available at: www.corevih.org. Accessed June 27, 2013.
-
4.
Kazanji M, Gessain A, 2003. Human T-cell lymphotropic virus types I and II (HTLV-I/II) in French Guiana: clinical and molecular epidemiology. Cad Saude Publica 19: 1227–1240.
-
5.
Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E, 2007. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 7: 266–281.
-
6.
Plancoulaine S, Gessain A, Joubert M, Tortevoye P, Jeanne I, Talarmin A, de Thé G, Abel L, 2000. Detection of a major gene predisposing to human T lymphotropic virus type I infection in children among an endemic population of African origin. J Infect Dis 182: 405–412.
-
7.
Casoli C, Pilotti E, Bertazzoni U, 2007. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression. AIDS Rev 9: 140–149.
-
8.
Beilke MA, Traina-Dorge VL, Sirois M, Bhuiyan A, Murphy EL, Walls JM, Fagan R, Winsor EL, Kissinger PJ, 2007. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection. Clin Infect Dis 44: 1229–1234.
-
9.
Brites C, Sampalo J, Oliveira A, 2009. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression. AIDS Rev 11: 8–16.
-
10.
Sobesky M, Couppie P, Pradinaud R, Godard MC, Alvarez F, Benoit B, Carme B, Lebeux P, 2000. Coinfection with HIV and HTLV-I infection and survival in AIDS stage. French Guiana Study. GECVIG (Clinical HIV Study Group in Guiana). Presse Med 29: 413–416.
-
11.
Cabié A, 2012. Activity Report of the COREVIH Martinique. Available at: http://www.sfls.aei.fr/ckfinder/userfiles/files/BAO-CoreVIH/bao8/RA_2011_COREVIH_Martinique.pdf. Accessed June 27, 2013.
-
12.
Césaire R, Lagathu G, Lézin A. 2005. HTLV1 and associated diseases in the French Antilles and French Guiana. Revue Francophone des Laboratoires 2005: 35–44.
-
13.
Plancoulaine S, Buigues RP, Murphy EL, van Beveren M, Pouliquen JF, Joubert M, Rémy F, Tuppin P, Tortevoye P, de Thé G, Moreau JP, Gessain A, 1998. Demographic and familial characteristics of HTLV-1 infection among an isolated, highly endemic population of African origin in French Guiana. Int J Cancer 76: 331–336.
-
14.
Beilke MA, Theall KP, Megan O, Clayton JL, Benjamin SM, Winsor EL, Kissinger PJ, 2004. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2. Clin Infect Dis 39: 256–263.
-
15.
Schechter M, Harrison LH, Halsey NA, Trade G, Santino M, Moulton LH, Quinn TC, 1994. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression. JAMA 271: 353–357.
-
16.
Oni T, Djossou F, Joubert M, Heraud JM, 2006. Awareness of mother-to-child transmission of human T-cell lymphotropic virus (HTLV) type I through breastfeeding in a small group of HTLV-positive women in Maripasoula and Papaichton, French Guiana. Trans R Soc Trop Med Hyg 100: 715–718.
-
17.
Schechter M, Moulton LH, Harrison LH, 1997. HIV viral load and CD4+ lymphocyte counts in subjects coinfected with HTLV-I and HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol 15: 308–311.
-
18.
Brites C, Alencar R, Gusmao R, Pedroso C, Netto EM, Pedral-Sampaio D, Badaró R, 2001. Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, Brazil. AIDS 15: 2053–2055.
-
19.
Gudo ES, Bhatt NB, Bila DR, Abreu CM, Tanuri A, Savino W, Silva-Barbosa SD, Jani IV, 2009. Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS? BMC Infect Dis 9: 211.
-
20.
Scapellato PG, Bottaro E, Brieschke MT, Scapellato JL, Dato A, Intile AD, Davaro R, Vidal GI, 2003. CD4 cell count among HIV-infected patients with an AIDS-defining disease: higher count in patients coinfected than in those not coinfected with human T-cell lymphotropic virus type I. J Acquir Immune Defic Syndr 33: 279–280.
-
21.
Bessinger R, Beilke M, Kissinger P, Jarrott C, Tabak OF, 1997. Retroviral coinfections at a New Orleans HIV outpatient clinic. J Acquir Immune Defic Syndr Hum Retrovirol 14: 67–71.
-
22.
Harrison LH, Quinn TC, Schechter M, 1997. Human T cell lymphotropic virus type I does not increase human immunodeficiency virus viral load in vivo. J Infect Dis 175: 438–440.
-
23.
Cardoso DF, Souza FV, Fonseca LA, Duarte AJ, Casseb J, 2009. Influence of human T-cell lymphotropic virus type 1 (HTLV-1) infection on laboratory parameters of patients with chronic hepatitis C virus. Rev Inst Med Trop Sao Paulo 51: 325–329.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 317 | 263 | 5 |
| Full Text Views | 283 | 10 | 1 |
| PDF Downloads | 65 | 9 | 1 |